Athenahealth has reportedly received multiple offers from organizations seeking to acquire the health IT company, sources told CNBC.
Two unnamed private equity firms and one unnamed strategic buyer have shown interest in the company, the sources said. The bids are reportedly not much above athenahealth's stock price of $131, up roughly 2.3 percent on Sept. 27.
Jeff Immelt, athenahealth executive chairman, confirmed in July that the board was considering a sale, merger or keeping the company an independent entity.
Elliott Management, Paul Singer's activist investment fund, kicked off athenahealth's potential sale with an unsolicited all-cash bid of $160 per share in May. The firm, once favored to acquire the company, has since rescinded its offer.